Biotechnology Case Study: Applied BioMath
24/7 Article Access Accelerates
The Research Process
Applied BioMath is an innovative biotech startup that helps its customers elevate and accelerate their drug discovery and development processes. Faced with a pressing need to rapidly acquire research articles across a broad range of journals, they deployed Article Galaxy.
About Applied BioMath
Applied BioMath helps pharmaceutical companies accelerate and de-risk drug development with mathematical modeling and simulation.
Quick Facts:
Founded: 2013
Headquarters: Concord, MA
Headcount: 25-30 Employees
Industry: Biotechnology
Why Article Galaxy?
Applied BioMath leverages Article Galaxy to save time and money on literature search and retrieval. Solution highlights include:
• Easy access to full-text articles, 24/7
• Integrated literature search
• Duplicate order alerts
The Challenge
Because Applied BioMath works across multiple areas of biomedicine, its research team needs fast access to a broad range of scientific journals. As a young startup, however, it did not have a research solution in place.
To get the information they needed, team members had to go through the time-consuming and often costly process of finding and accessing literature from individual publisher websites. As the company grew, improving efficiency became a top priority.
Research Solutions is committed to providing customers with a solution that's custom fit for them. Our customer service team is available 24/7 offering support when you need it.
The Solution
To address its growing research needs, Applied BioMath selected Research Solutions’ Article Galaxy platform based on the following criteria:
Speed:
Easy article access—and delivery within minutes—saves time and accelerates research.
Coverage:
A broad portfolio of publishers—and integration with PubMed, Google Scholar, and 70 other search portals—ensures comprehensive discovery.
Convenience:
A centralized platform simplifies the workflow, prevents duplicate orders, and facilitates copyright compliance.